EDSA financials

Edesa Biotech (EDSA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

EDSA income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$7.91M-$7.19M-1.27
2024––-$7.01M-$6.17M-1.93
2023––-$9.22M-$8.37M-2.93
2022––-$18.37M-$17.55M–
2021$0.00$0.00-$23.68M-$13.34M-1.10
2020$328.80K$311.20K-$6.40M-$6.36M-0.74